DiscoverThe Lancet Microbe in conversation withMichael Otto on using probiotics to reduce Staphylococcus aureus
Michael Otto on using probiotics to reduce Staphylococcus aureus

Michael Otto on using probiotics to reduce Staphylococcus aureus

Update: 2023-01-13
Share

Description

Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand.

Read the full article:
Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Michael Otto on using probiotics to reduce Staphylococcus aureus

Michael Otto on using probiotics to reduce Staphylococcus aureus

The Lancet Microbe